Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Empyema in a woman with cystic fibrosis: a cautionary tale.

Coates A, Schaefer O, Uy K, O'Sullivan BP.

Case Rep Pulmonol. 2013;2013:159508. doi: 10.1155/2013/159508. Epub 2013 Mar 5.

2.

Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.

Conway SP, Brownlee KG, Denton M, Peckham DG.

Am J Respir Med. 2003;2(4):321-32. Review.

PMID:
14719998
3.

Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.

Campana S, Taccetti G, Ravenni N, Masi I, Audino S, Sisi B, Repetto T, Döring G, de Martino M.

J Cyst Fibros. 2004 Aug;3(3):159-63.

4.

The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?

Banerjee D, Stableforth D.

Drugs. 2000 Nov;60(5):1053-64. Review.

PMID:
11129122
5.
6.

Empyema due to a highly transmissible Pseudomonas aeruginosa strain in an adult cystic fibrosis patient.

Mohan K, Lakshman V, Fothergill JL, Ledson MJ, Winstanley C, Walshaw MJ.

J Med Microbiol. 2010 May;59(Pt 5):614-6. doi: 10.1099/jmm.0.014696-0. Epub 2010 Feb 4.

PMID:
20133415
7.

Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis.

Dales L, Ferris W, Vandemheen K, Aaron SD.

Eur J Clin Microbiol Infect Dis. 2009 Oct;28(10):1275-9. doi: 10.1007/s10096-009-0774-9. Epub 2009 Jul 3.

PMID:
19575248
8.

Microbial Pathogens Associated With Cystic Fibrosis: Special Focus on Pseudomonas aeruginosa.

Barth AL, Pitt TL.

Braz J Infect Dis. 1998 Apr;2(2):43-61.

PMID:
11101911
9.

Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.

Hendry J, Butler S, Elborn JS, Govan JR, Nelson J, Shale DJ, Webb AK.

J Infect. 2000 Mar;40(2):164-70.

PMID:
10841094
10.

Cedecea davisae's Role in a Polymicrobial Lung Infection in a Cystic Fibrosis Patient.

Ismaael TG, Zamora EM, Khasawneh FA.

Case Rep Infect Dis. 2012;2012:176864. doi: 10.1155/2012/176864. Epub 2012 Dec 23.

11.

Pulmonary infections in patients with cystic fibrosis.

Rajan S, Saiman L.

Semin Respir Infect. 2002 Mar;17(1):47-56. Review.

PMID:
11891518
12.

Cystic fibrosis and endobronchial pseudomonas infection.

Høiby N.

Curr Opin Pediatr. 1993 Jun;5(3):247-54. Review.

PMID:
7690637
13.

Microbiology of lung infection in cystic fibrosis.

Govan JR, Nelson JW.

Br Med Bull. 1992 Oct;48(4):912-30. Review.

PMID:
1281036
15.

Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.

Worlitzsch D, Rintelen C, Böhm K, Wollschläger B, Merkel N, Borneff-Lipp M, Döring G.

Clin Microbiol Infect. 2009 May;15(5):454-60. doi: 10.1111/j.1469-0691.2008.02659.x. Epub 2009 Jan 22.

16.

Susceptibility of Burkholderia cepacia and other pathogens of importance in cystic fibrosis to u.v. light.

Cairns G, Kerr KG, Beggs CB, Sleigh PA, Mooney L, Keig P, Donnelly JK.

Lett Appl Microbiol. 2001 Mar;32(3):135-8.

17.

Isolation of Pseudomonas cepacia in cystic fibrosis patient.

Marques Ede A, Pinto RM, Dallallana LT, de Oliveira EF, Suassuna I.

Mem Inst Oswaldo Cruz. 1993 Jan-Mar;88(1):125-9.

18.

Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues.

Waters V, Ratjen F.

Expert Rev Anti Infect Ther. 2006 Oct;4(5):807-19. Review.

PMID:
17140357
19.

Pseudomonas aeruginosa: role in the pathogenesis of the CF lung lesion.

Currie AJ, Speert DP, Davidson DJ.

Semin Respir Crit Care Med. 2003 Dec;24(6):671-80.

PMID:
16088583
20.

Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia.

Tomlin KL, Coll OP, Ceri H.

Can J Microbiol. 2001 Oct;47(10):949-54.

PMID:
11718549
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk